|
Registrat Mapi (France) / Mapi Consultancy
|
|
Novartis Pharmaceuticals Corporation (USA) / Mapi Values
|
|
Black Betty S, Kasper Judith D and Rabins Peter V - Johns Hopkins Medical Institutions (USA) -
|
|
Pfizer (France) / Mapi Values
|
|
The European Restless Legs Syndrome Study Group (EURLSSG)
|
|
Alice Dazord and Sabine Manificat (France)
|
|
Florence I. Mahoney and Dorothea W. Barthel.
|
|
Thys van der Molen (The Netherlands)
|
|
Pusic AL, Cano S, Klassen A (USA)
|
|
Thys van der Molen (The Netherlands)
|
|
Sanofi-Aventis (France) / Mapi Values
|
|
Richard S. Irwin and Cynthia T. French (USA)
|
|
Janssen Global Services (USA) / Mapi Values
|
|
Didier Bouhassira (France)
|
|
Murray W. Johns (Australia)
|
|
Guyonnet D, Chassany O et al. for Danone (France) / Mapi Values
|
|
Olivier Chassany, Parke Davis (France) / Mapi Values
|
|
Burckhardt CS, Clark SR, Bennett RM (USA)
|
|
Bennett RM, Friend R (USA)
|
|
Serge Perrot & Didier Bouhassira (France)
|
|
Janssen Global Services (USA)
|
|
David P Goldberg - GL Assessment (UK)
|
|
Bausch & Lomb Chauvin (France) / Mapi Values
|
|
Janssen Global Services (USA)
|
|
Snaith RP and Zigmond AS - GL Assessment (UK)
|
|
Abbott (France) / Mapi Values
|
|
Donald L Patrick, Douglas Drossman, Novartis Pharmaceuticals Corporation (USA)
|
|
Thys van der Molen (The Netherlands)
|
|
Thys van der Molen (The Netherlands)
|
|
Kelly Vincent, Alison Carr and Michael Rose (UK)
|
|
International Restless Legs Syndrome Study Group (USA)
|
|
Pfizer (France) / Mapi Values
|
|
Linda Cardozo and Con Kelleher (UK)
|
|
Raymond Rosen (USA) and Sanofi-Aventis (France)
|
|
Ljubica Besker-Ivasovic (Switzerland)
|
|
Jeffrey L. Cummings (USA)
|
|
Brad Galer and Mark Jensen (USA)
|
|
Didier Bouhassira (France)
|
|
Bausch & Lomb Chauvin (France) / Mapi Values
|
|
Janssen Global Services (USA)
|
|
Bausch & Lomb Chauvin (France) / Mapi Values
|
|
Boehringer Ingelheim Pharma (Germany) / Mapi Values
|
|
Janssen Global Services (USA) / Mapi Values
|
|
Janssen Global Services (USA)
|
|
Merck Sharp & Dohme Corp. a subsidiary of Merck & Co, Inc |
|
Sanofi-Aventis (France) / Mapi Values
|
|
Janssen Global Services (USA) / Mapi Values
|
|
Janssen Global Services (USA)
|
|
Pierre Fabre Médicament (France) / Mapi Values
|
|
Angela de Boer (The Netherlands)
|
|
Ray Chaudhuri (UK), Claudia Trenkwalder (Germany) and Ralf Kohnen (Germany)
|
|
Paediatric version of the HADS GL Assessment (UK)
|
|
Brad Galer, Mark Jensen, and Arnold Gammaitoni (USA)
|
|
Brad Galer, Mark Jensen, and Arnold Gammaitoni (USA)
|
|
Mapi Consultancy / Mapi Values
|
|
Buysse Daniel J, Berman Susan R, Kupfer David J, Monk Timothy H, Reynolds Charles F (USA)
|
|
QUAL HEMO scientific committee / BAXTER / Mapi Values
|
|
Servier (France) / Mapi Values
|
|
Laboratoire Houdé (Aventis), Sanofi Aventis, Michel Amouretti, Jean-Pierre Galmiche and Thierry Poynard (France), Mapi Values
|
|
Psychological Applications LLC (USA) and Donald A. Mahler (USA)
|
|
Ronald Melzack (Canada) and IMMPACT (USA)
|
|
Véronique Bonniaud, Dianne Bryant, Pr. Gordon Guyatt, Pr Bernard Parratte and COLOPLAST (France, Canada) / Mapi Values
|
|
Merck US and Michael O'Leary, (USA)
|
|
Pfizer (France) / Mapi Values
|
|
Gilson Betty, Bergner Marilyn / The Johns Hopkins University (USA)
|
|
Bennett RM, Friend R (USA)
|
|
Mary-Margaret Chren (USA)
|
|
Philippe Ravaud and Viet-Thi Tran (France)
|
|
Bertrand Lukacs and Sanofi-Aventis (France)
|
|
French Association of Urology (France) / Mapi Values
|